Development
MFS Emerging Markets Debt Fund Class R2
MEDEX
NASDAQ
| Weiss Ratings | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | MFS | |||
| Manager/Tenure (Years) | Ward Brown (16), Neeraj Arora (5) | |||
| Website | http://www.mfs.com | |||
| Fund Information | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | MFS Emerging Markets Debt Fund Class R2 | |||
| Category | Emerging Markets Bond | |||
| Sub-Category | Emerging Markets Fixed Income | |||
| Prospectus Objective | Diversified Emerging Markets | |||
| Inception Date | Dec 01, 2008 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 6.26% | |||
| Dividend | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | -- | |||
| Asset Allocation | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.06% | |||
| Stock | 0.00% | |||
| U.S. Stock | 0.00% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 98.94% | |||
| U.S. Bond | 11.89% | |||
| Non-U.S. Bond | 87.05% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.13% | |||
| 30-Day Total Return | -0.49% | |||
| 60-Day Total Return | 0.80% | |||
| 90-Day Total Return | 2.12% | |||
| Year to Date Total Return | 2.12% | |||
| 1-Year Total Return | 7.11% | |||
| 2-Year Total Return | 17.66% | |||
| 3-Year Total Return | 10.34% | |||
| 5-Year Total Return | 21.01% | |||
| Price | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $12.09 | |||
| 1-Month Low NAV | $12.06 | |||
| 1-Month High NAV | $12.23 | |||
| 52-Week Low NAV | $11.74 | |||
| 52-Week Low NAV (Date) | Apr 16, 2024 | |||
| 52-Week High NAV | $12.46 | |||
| 52-Week High Price (Date) | Oct 01, 2024 | |||
| Beta / Standard Deviation | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.01 | |||
| Standard Deviation | 10.31 | |||
| Balance Sheet | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 7.07B | |||
| Operating Ratios | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.31% | |||
| Turnover Ratio | 58.00% | |||
| Performance | MEDEX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 7.38% | |||
| Last Bear Market Total Return | -11.69% | |||